Zobrazeno 1 - 10
of 26
pro vyhledávání: '"T B Christensen"'
Autor:
Sandrine Marreaud, Peter Reichardt, Daniel Pink, Søren Daugaard, T B Christensen, J.-Y. Blay, Ole S. Nielsen, M. van Glabbeke, Cédric Hermans, Ian Judson
Publikováno v:
Nielsen, O S, Reichardt, P, Christensen, T B, Pink, D, Daugaard, S, Hermans, C, Marreaud, S, van Glabbeke, M, Blay, J & Judson, I 2006, ' Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas ', European Journal of Cancer, vol. 42, no. 14, pp. 2303-9 . https://doi.org/10.1016/j.ejca.2006.04.011
This phase I study evaluated the toxicity of first-line combined pegylated liposomal doxorubicin (Caelyx®) and ifosfamide in patients with advanced and/or metastatic soft tissue sarcomas. Five dose levels (L) were studied: Caelyx® 30 mg/m2 (L1–4)
Publikováno v:
British Journal of Cancer
We have recently introduced 125I-hCG as an elimination marker in patients with human chorionic gonadotrophin (hCG) producing testicular cancer. 125I-hCG is a well-known reagent in clinical biochemistry and is used extensively in hCG assays. Previous
Publikováno v:
British Journal of Cancer. 80:1582-1587
Publikováno v:
British Journal of Cancer
The rate of reduction in the concentration of serum human chorionic gonadotrophin (hCG) following chemotherapy for germ cell tumours may follow a complex pattern, with longer apparent half-life during later stages of chemotherapy, even in patients tr
Autor:
J. Moeller, L. Vichi, Alexander Senning, L. Martiny, T. B. Christensen, Karl Anker Joergensen, Finn K. Larsen
Publikováno v:
ChemInform. 24
Autor:
Sandrine Marreaud, Ole S. Nielsen, Patrick Schöffski, Sebastian Bauer, Peter Reichardt, Joerg T. Hartmann, T B Christensen, Søren Daugaard, M. van Glabbeke, Daniel Pink, J.-Y. Blay
Publikováno v:
Reichardt, P, Nielsen, O S, Bauer, S, Hartmann, J T, Schöffski, P, Christensen, T B, Pink, D, Daugaard, S, Marreaud, S, Van Glabbeke, M & Blay, J Y 2007, ' Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group. ', European Journal of Cancer, vol. 43, no. 6, pp. 1017-22 . https://doi.org/10.1016/j.ejca.2007.01.014
No standard treatment is established for patients with advanced soft tissue sarcoma after previous chemotherapy with anthracyclines and ifosfamide, given either in combination or sequentially. Exatecan (DX-8951f) is a totally synthetic analogue of th
Publikováno v:
Clinical physiology (Oxford, England). 20(2)
In the lower range of cardiac output (CO, up to 15 l min-1), we found an excellent agreement between CO measured by bioimpedance and carbon dioxide rebreathing techniques. CO estimated by bioimpedance was generally lower. The bioimpedance method had
Publikováno v:
Ugeskrift for laeger. 161(16)
New trial have shown that immediate regional lymph node dissection offers increased survival in patients with regional lymph node metastases only. Introduction of isotope technique to identify the first node, the sentinel node (SN), receiving lymph f
Publikováno v:
Ugeskrift for laeger. 161(16)
Autor:
T B, Christensen
Publikováno v:
Ugeskrift for laeger. 159(25)